Approval · Notice of Compliance 18267 · 2016

TRELSTAR: Notice of Compliance 18267

Issued July 13, 2016

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 18267
Date: July 13, 2016
Company: Allergan Pharma Co.Markham, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change

Products in this notice

Brand	DIN	Status today
TRELSTAR	02240000	Marketed
TRELSTAR	02243856	Marketed
TRELSTAR	02412322	Marketed

Medicinal ingredients

TRIPTORELIN PAMOATE 3.75 MG per VIAL
TRIPTORELIN PAMOATE 11.25 MG per VIAL
TRIPTORELIN PAMOATE 22.5 MG per VIAL